A phase IB clinical trial to evaluate the safety and immunogenicity of a multiclade HIV-1 DNA plasmid vaccine, VRC-HIVDNA009-00VP, administered at 2 different dosing schedules, in HIV-1-uninfected adult participants
Phase of Trial: Phase I/II
Latest Information Update: 31 Mar 2015
At a glance
- Drugs VRC-HIVDNA009-00-VP (Primary)
- Indications HIV infections
- Focus Adverse reactions; Pharmacodynamics
- 05 Oct 2007 Status changed from in progress to completed.
- 08 Nov 2005 New trial record.